BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 119882
Published online Sep 25, 2026. doi: 10.5527/wjn.119882
Figure 1
Figure 1 Venn plot: 137 microRNAs significantly differed between immunoglobulin A nephropathy cases and healthy controls. Of 215 microRNAs significantly differed between immunoglobulin A nephropathy cases and disease controls. It was found that 37 microRNAs commonly differentiated immunoglobulin A nephropathy cases from healthy controls and disease controls. IgAN: Immunoglobulin A nephropathy; HC: Healthy controls; DC: Disease controls.
Figure 2
Figure 2 Principal component analysis of 37 microRNA profiles shows that they can significantly differentiate between immunoglobulin A nephropathy cases, disease controls, and healthy controls compared to all the 798 microRNAs in the nanostring gene panel (left panel). PC: Principal component.
Figure 3
Figure 3 Workflow analysis. IgAN: Immunoglobulin A nephropathy; HC: Healthy controls; DC: Disease controls; miRNA: Micro ribonucleic acid; ORA: Over-representation analysis; MNDR: Mammal non-coding RNA-disease repository; LOOCV: Leave-one-out cross-validation; AUROC: Area under the receiver operating characteristic curve; LASSO: Least absolute shrinkage and selection operator; AUC: Area under the curve; ROC: Receiver operator curve.
Figure 4
Figure 4 Least absolute shrinkage and selection operator coefficient plot showing 15 microRNAs that can differentiate immunoglobulin A nephropathy cases from healthy controls. miRNA: MicroRNA.
Figure 5
Figure 5  Shows the network of nine microRNAs (yellow), pathways enriched (in boxes), experimentally targeted messenger RNA (purple oval), and disease association (in pink).


Write to the Help Desk